ITC Will Probe Hemophilia B Med Patent Infringement Claims
By Steven Trader · August 9, 2017, 4:45 PM EDT
The U.S. International Trade Commission has agreed to take up an investigation into whether the importer of a drug used to treat hemophilia B is infringing patents for a similar drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login